Latest Health News
EssilorLuxottica and Meta to launch Oakley Meta, creating a new category of Performance AI glasses for athletes and fans alike
EssilorLuxottica and Meta to launch Oakley Meta, creating a new category of…
Actuate Therapeutics Reports Positive Biomarker and Machine Learning Data from Phase 2 Elraglusib Trial in First-Line Treatment of Metastatic Pancreatic Cancer at ASCO
Phase 2 highlights robust biomarker identification and survival correlations in first-line metastatic…
Superlab Suisse to Open New Facility at Campus Biotech in Geneva in January 2026
Zurich, June 19, 2025 (GLOBE NEWSWIRE) -- Superlab Suisse has announced the…
Kansas State University Veterinary Health Center Adopts Instinct EMR, Retires Legacy System
June 19, 2025 10:01 ET | Source: Instinct Science PHILADELPHIA, June 19,…
Unyte Health Launches Sonocea Enhanced Rest and Restore Protocol: Revolutionary Approach for Nervous System Regulation
DENVER, June 19, 2025 (GLOBE NEWSWIRE) -- Unyte Health, a leader in…
Vincerx Pharma, Inc. Announces Adjournment of Special Meeting – Will Reconvene Meeting on July 16, 2025 to Secure Votes Needed to Approve Dissolution Proposal
SAN MATEO, Calif., June 18, 2025 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc.…
Annexon Bolsters Ophthalmology Expertise with Appointment of Retina Specialist Lloyd Clark, M.D., as Pivotal ANX007 Program Advances in Dry Age-Related Macular Degeneration (AMD) with Geographic Atrophy (GA)
June 18, 2025 16:05 ET | Source: Annexon Biosciences Dr. Clark Brings…
Galapagos Presented New Data at ICML 2025 From Cohort 3 of ATALANTA-1 in Relapsed/Refractory Indolent NHL Patients, Demonstrating High Complete Response and MRD Negativity Rates With CAR-T Candidate GLPG5101
Of the 34 patients enrolled in Cohort 3 of the ATALANTA-1 Phase…
PolyPid Secures $26.7 Million Through Warrant Exercise Following Successful SHIELD II Phase 3 Trial Results
June 16, 2025 19:20 ET | Source: PolyPid Ltd. The Company Anticipates…
